Pricing Log in Create free account

Lite Strategy, Inc. (LITS) vs NanoViricides, Inc. (NNVC)

Lite Strategy, Inc. and NanoViricides, Inc. are both Biotechnology companies. Lite Strategy, Inc. and NanoViricides, Inc. are of similar size ($36.3M and $35.0M). Across the 9 metrics below, NanoViricides, Inc. leads on 6 and Lite Strategy, Inc. on 3.

Valuation

Metric LITS NNVC Biotechnology median
P/E n/m n/m 8.50
P/S 0.37 n/m 9.71
P/B 0.95 3.21 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.32 n/m 9.21
Earnings yield (179.62%) (28.89%) (33.15%)
Free cash flow yield (264.16%) (27.93%) (25.50%)

Profitability

Metric LITS NNVC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (243.02%) (101.46%) (56.36%)
Return on assets (233.37%) (87.91%) (48.04%)
Return on invested capital (115.85%) (88.16%) 0.00%

Growth

Metric LITS NNVC Biotechnology median
Revenue growth (TTM) 152.90% — 6.02%
EPS growth (last fiscal year) 13.86% 35.38% 30.26%
Revenue growth, 5-year CAGR 67.75% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LITS NNVC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.74 2.66 4.72
Net debt to EBITDA 0.09 0.36 0.96

Dividend

Metric LITS NNVC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LITS NNVC Biotechnology median
Market cap 36.34m 34.97m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack